
Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
We investigated the prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast most cancers sufferers. BCL1 and BCL2 expression statuses had been assessed by immunohistochemistry utilizing tissue microarrays from 393 breast most cancers sufferers. The Kaplan-Meier estimator and log-rank check had been used for survival analyses. The Cox proportional hazards mannequin was used to calculate hazard ratio (HR) and the 95% confidence interval (CI) of survival analyses. BCL1 expression revealed no affect on survival. The excessive BCL2 group confirmed superior disease-free survival in contrast with the low BCL2 group (p = 0.002), particularly concerning native recurrence-free survival (p = 0.045) and systemic recurrence-free survival (p = 0.002).
BCL2 expression was a big prognostic issue by univariable evaluation (HR, 0.528; 95% CI, 0.353-0.790; p = 0.002) and by multivariable evaluation (HR, 0.547; 95% CI, 0.362-0.826; p = 0.004). Excessive BCL2 expression was related to greater disease-free survival within the hormone receptor (HRc)-positive and human epidermal progress issue receptor 2 (HER2)-negative (HRc(+)/HER2(-)) subtype solely (p = 0.002). The excessive BCL2 group was related to optimistic estrogen receptor (ER), optimistic progesterone receptor (PR), low histologic grade, and age ≤ 50 years.
BCL1 expression had no prognostic affect, however BCL2 expression was a big unbiased prognostic issue. Excessive BCL2 expression was related to greater disease-free survival, particularly concerning native recurrence and systemic recurrence. The prognostic impact of BCL2 expression was efficient solely within the HRc(+)/HER2(-) subtype. Favorable clinicopathologic options and a robust affiliation with the ER/PR standing might partly clarify the superior prognosis of the excessive BCL2 group. BCL2 expression could possibly be utilized to evaluate the prognosis of breast most cancers sufferers in scientific settings.
Predicting ROR1/BCL2 mixture focused remedy of small cell carcinoma of the lung
Small cell lung most cancers (SCLC) stays a lethal type of most cancers, with a 5-year survival fee of lower than 10 %, necessitating novel therapies. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an oncofetal protein that’s rising as a therapeutic goal and is co-expressed with BCL2 in a number of tumor varieties as a result of microRNA coregulation. We hypothesize that ROR1-targeted remedy is efficient in small cell lung most cancers and synergizes with therapeutic BCL2 inhibition.
- Tissue microarrays (TMAs) and formalin-fixed paraffin-embedded (FFPE) SCLC affected person samples had been utilized to find out the prevalence of ROR1 and BCL2 expression in SCLC. Eight SCLC-derived cell strains had been used to find out the antitumor exercise of a small molecule ROR1 inhibitor (KAN0441571C) alone and together with the BCL2 inhibitor venetoclax.
- The Chou-Talalay technique was utilized to find out synergy with the drug mixture. ROR1 and BCL2 protein expression was recognized in 93% (52/56) and 86% (48/56) of SCLC affected person samples, respectively. Equally, ROR1 and BCL2 had been proven by qRT-PCR to have elevated expression in 79% (22/28) and 100% (28/28) of SCLC affected person samples, respectively. KAN0441571C displayed efficacy in eight SCLC cell strains, with an IC50 of 500 nM or much less.
- Synergy as outlined by a mixture index of <1 through the Chou-Talalay technique between KAN0441571C and venetoclax was demonstrated in eight SCLC cell strains. Now we have proven that ROR1 inhibition is synergistic with BCL2 inhibition in SCLC fashions and reveals promise as a novel therapeutic goal in SCLC.
Expression and Practical Evaluation of the BCL2-Related Agonist of Cell Dying (BAD) Gene in Grass Carp (Ctenopharyngodon idella) Throughout Bacterial An infection
The BCL2-associated agonist of cell dying protein is a key participant in apoptosis depending on mitochondria and in illness development that includes the regulation of cell dying, reminiscent of tumorigenesis, diabetes, sepsis shock, and epilepsy. Nonetheless, the mechanisms underlying the immune responses to teleost BAD bacterial an infection and mitochondrial-dependent apoptosis stays unclear. So as to elucidate the mechanisms concerned, on this examine, a Ctenopharyngodon idella (grass carp) BAD gene named GcBAD1 was firstly cloned and characterised.
The outcomes indicated that the ORF (open studying body) of GcBAD1 was 438 bp in size, encoding a 145-amino acid putative protein of 16.66 kDa. This deduced amino acid sequence has a greater id than one other teleost species in keeping with a phylogenetic evaluation, and accommodates a Bcl2-BAD-1 area. In wholesome grass carp fish, the mRNA transcripts of GcBAD1 had been extensively current within the studied tissues, which could possibly be ranked as follows; spleen > mind > middle-kidney > head-kidney > liver > gills > intestines > coronary heart and muscle. As well as, throughout an infection by Aeromonas hydrophila and Staphylococcus aureus, the mRNA transcription and protein ranges expression of GcBAD1 within the head-kidney, spleen, and liver tissues of the fish had been considerably up-regulated.
Furthermore, when the C. idellus kidney cell line (CIK) cells had been incubated with Lipopolysaccharide (LPS) and lipoteichoic acid (LTA), the GcBAD1 expression transcripts had been additionally considerably up-regulated. Moreover, overexpression of GcBAD1 in CIK cells was in a position to activate apoptosis-related genes, together with these encoding p53, Cytochrome C (CytoC), caspase-3, and caspase-9.
Apart from, within the TUNEL assays, when pEGFP-BAD1 was over-expressed, the variety of crimson indicators related to apoptosis had been considerably elevated within the CIK cells contaminated with LPS or LTA at 12 h. This examine demonstrates that GcBAD1 has a big position within the mitochondrial apoptosis pathway of grass carp’s innate immunity. Our findings present new perception into the potential mechanisms of teleost antibacterial immunity.

Examine on results of miR-141-3p in proliferation, migration, invasion and apoptosis of colon most cancers cells by inhibiting Bcl2
Function: This examine aimed to research the connection between miR-141-3p and B lymphocyte-2 gene (Bcl2) gene and its organic conduct on colon most cancers cell line SW480.
Strategies: qRT-PCR was used to detect the expression degree of miR-141-3p in colon most cancers tissues and adjoining tissues, in addition to in colon most cancers cell line and regular human colonic epithelial cell line FHC. MTT assay, wound assay, and Transwell demonstrated the consequences of miR-141-3p on colon most cancers proliferation, migration and invasion. Targetscan7.1 predictive software program and twin luciferase reporter assays had been used to detect the focused regulation of miR-141-3p on the apoptosis-related gene Bcl2. MTT assay, wound assay, Transwell and circulation cytometry had been used to detect the impact of Bcl2 on miR-141-3p on colon most cancers proliferation, migration, invasion and apoptosis.
Outcomes: In contrast with adjoining tissues, the expression of miR-141-3p in colon most cancers tissues was considerably down-regulated. Colon most cancers sufferers with low expression of miR-141-3p had poorer prognosis. In contrast with regular colonic epithelial cells, miR-141-3p expression was considerably down-regulated in colon most cancers cell strains, and overexpression of miR-141-3p considerably attenuated the proliferation, migration and invasion of colon most cancers cells.
Knockdown of miR-141-3p considerably promoted the proliferation, migration and invasion of colon most cancers cells. miR-141-3p targets the unfavorable regulation of Bcl2. Knockdown of Bcl2 considerably attenuated the promotion of miR-141-3p inhibitor on proliferation, migration and invasion of colon most cancers cells and inhibition of apoptosis. Knockdown of Bcl2 considerably enhanced the inhibition impact of miR-141-3p inhibitor on proliferation, migration and invasion of colon most cancers cells.
Conclusions: In conclusion, miR-141-3p can inhibit the most cancers by regulating Bcl2, and miR-141-3p has the potential to grow to be a possible therapeutic goal for colon most cancers.
Key phrases: Bcl2; Colon most cancers; Malignant organic conduct; miR-141-3p.
![]() Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-500ug |
|||
QP6168-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
![]() Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-50ug |
|||
QP6168-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
![]() Argininosuccinate Lyase (Recombinant) |
|||
20-abx073248 | Abbexa |
|
|
![]() Cystathionine β-lyase, Recombinant |
|||
NATE-1146 | Creative Enzymes | 100mg | EUR 712.8 |
![]() Recombinant human Selenocysteine lyase |
|||
P2183 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Selenocysteine lyase |
![]() Selenocysteine Lyase Recombinant Protein |
|||
92-018 | ProSci | 0.05 mg | EUR 852.9 |
Description: Selenocysteine Lyase belongs to the class-V pyridoxal-phosphate-dependent aminotransferase family. Selenocysteine Lyase exists as a homodimer in the cytosol. In the brain, Selenocysteine Lyase is as an enzyme that putatively salvages Sec and recycles the selenium for selenoprotein translation. Selenocysteine Lyase catalyzes the decomposition of L-selenocysteine to L-alanine and elemental selenium. Selenocysteine Lyase can be up-regulated In acute glomerulonephritis, it can also be regulated by JUN/AP-1. |
![]() HMGCL 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Human Recombinant Protein |
|||
PROTP35914 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: HMGCL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 323 amino acids (28-325) and having a molecular mass of 34.2kDa.;HMGCL is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
![]() Recombinant Cystathionine Gamma Lyase (CSE) |
|||
4-RPB538Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Cystathionine Gamma Lyase expressed in: E.coli |
![]() Recombinant Cystathionine Gamma Lyase (CSE) |
|||
4-RPB538Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Cystathionine Gamma Lyase expressed in: E.coli |
![]() Recombinant Cystathionine Gamma Lyase (CSE) |
|||
4-RPB538Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Cystathionine Gamma Lyase expressed in: E.coli |
![]() E.Coli N-Acetylneuraminate Lyase (Recombinant) |
|||
20-abx073216 | Abbexa |
|
|
![]() Recombinant E.Coli N-Acetylneuraminate Lyase |
|||
7-03193 | CHI Scientific | 5µg | Ask for price |
![]() Recombinant E.Coli N-Acetylneuraminate Lyase |
|||
7-03194 | CHI Scientific | 20µg | Ask for price |
![]() Recombinant E.Coli N-Acetylneuraminate Lyase |
|||
7-03195 | CHI Scientific | 1mg | Ask for price |
![]() Homocysteine ?,?-Lyase (rHCYase), Active, Recombinant |
|||
P1117-200 | Biovision | each | EUR 510 |
![]() N-acetylneuraminate Pyruvate Lyase (Recombinant) |
|||
20-abx073214 | Abbexa |
|
|
![]() Recombinant Human Cystathionine γ-Lyase/CTH |
|||
CF60-10ug | Novoprotein | 10ug | EUR 175.2 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4. |
![]() Recombinant Human Cystathionine γ-Lyase/CTH |
|||
CF60-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4. |
![]() Recombinant Human Cystathionine γ-Lyase/CTH |
|||
CF60-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4. |
![]() Recombinant Human Cystathionine γ-Lyase/CTH |
|||
CF60-50ug | Novoprotein | 50ug | EUR 406.8 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4. |
![]() ATP citrate lyase recombinant monoclonal antibody |
|||
A5181 | Bimake | 100ul X 3 | EUR 714 |
Description: A recombinant monoclonal antibody from rabbit against human ATP citrate lyase for WB,ELISA |
![]() L-Methionine ?-Lyase, Pseudomonas putida recombinant |
|||
7848-100 | Biovision | each | EUR 189.6 |
![]() L-Methionine ?-Lyase, Pseudomonas putida recombinant |
|||
7848-500 | Biovision | each | EUR 464.4 |
![]() HMGCL Human, 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Human Recombinant Protein, Sf9 |
|||
PROTP35914-1 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: HMGCL Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 305 amino acids (28-325 a.a.) and having a molecular mass of 32.5kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa). HMGCL is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
![]() ASL Argininosuccinate Lyase Human Recombinant Protein |
|||
PROTP04424 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: ASL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 484 amino acids (1-464) and having a molecular mass of 53.8kDa.;ASL is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
![]() ADSL Adenylosuccinate Lyase Human Recombinant Protein |
|||
PROTP30566 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: ADSL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 520 amino acids (1-484) and having a molecular mass of 59kDa.;ADSL is fused to a 36 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
![]() Recombinant Sphingosine 1 Phosphate Lyase 1 (SGPL1) |
|||
4-RPE691Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Sphingosine 1 Phosphate Lyase 1 expressed in: E.coli |
![]() Recombinant Sphingosine 1 Phosphate Lyase 1 (SGPL1) |
|||
4-RPE691Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Sphingosine 1 Phosphate Lyase 1 expressed in: E.coli |
![]() Recombinant Human N-acetylneuraminate Pyruvate Lyase |
|||
7-03232 | CHI Scientific | 5µg | Ask for price |
![]() Recombinant Human N-acetylneuraminate Pyruvate Lyase |
|||
7-03233 | CHI Scientific | 20µg | Ask for price |
![]() Recombinant Human N-acetylneuraminate Pyruvate Lyase |
|||
7-03234 | CHI Scientific | 1mg | Ask for price |
![]() Recombinant Human Selenocysteine Lyase/SCLY (N-6His) |
|||
CE52-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0. |
![]() Recombinant Human Selenocysteine Lyase/SCLY (N-6His) |
|||
CE52-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0. |
![]() Recombinant Human Selenocysteine Lyase/SCLY (N-6His) |
|||
CE52-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0. |
![]() Recombinant Human Selenocysteine Lyase/SCLY (N-6His) |
|||
CE52-50ug | Novoprotein | 50ug | EUR 595.2 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0. |
![]() Hyaluronate Lyase from Streptococcus pyogenes, recombinant |
|||
NATE-0346 | Creative Enzymes | 10mg | EUR 440.4 |
![]() Recombinant 2-Hydroxyacyl Coenzyme A Lyase 1 (HACL1) |
|||
4-RPG361Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human 2-Hydroxyacyl Coenzyme A Lyase 1 expressed in: E.coli |
![]() NANA N-Acetylneuraminate Lyase E.Coli Recombinant Protein |
|||
PROTP0A6L4 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: NANA produced in E.Coli is a single, non-glycosylated polypeptide chain containing 317 amino acids (1-297 a.a.) and having a molecular mass of 34.7kDa.;NANA is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
![]() Recombinant Cysteine Conjugate Beta Lyase, Cytoplasmic (CCbL1) |
|||
4-RPD863Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Cysteine Conjugate Beta Lyase, Cytoplasmic expressed in: E.coli |
![]() L-Methionine γ-Lyase from Pseudomonas putida, Recombinant |
|||
NATE-1655 | Creative Enzymes | 50u | EUR 712.8 |
![]() NPL N-acetylneuraminate Pyruvate Lyase Human Recombinant Protein |
|||
PROTQ9BXD5 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: NPL produced in E.Coli is a single, non-glycosylated polypeptide chain containing 340 amino acids (1-320 a.a.) and having a molecular mass of 37.3kDa.;NPL is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-1mg |
|||
QP6448-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
![]() Recombinant E.coli Yersinia Pestis F1 capsule antigen (caf1) ( |
|||
YSP31-R-100 | Alpha Diagnostics | 100 ug | EUR 416.4 |
![]() Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-1mg |
|||
QP7508-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-10ug |
|||
QP6448-ec-10ug | EnQuireBio | 10ug | EUR 240 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-50ug |
|||
QP6448-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-1mg |
|||
QP6448-ye-1mg | EnQuireBio | 1mg | EUR 2763.6 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-100ug |
|||
QP6448-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-200ug |
|||
QP6448-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, E.coli-500ug |
|||
QP6448-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-10ug |
|||
QP6448-ye-10ug | EnQuireBio | 10ug | EUR 326.4 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-50ug |
|||
QP6448-ye-50ug | EnQuireBio | 50ug | EUR 424.8 |
![]() Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-100ug |
|||
QP7508-ec-100ug | EnQuireBio | 100ug | EUR 848.4 |
![]() Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-10ug |
|||
QP7508-ec-10ug | EnQuireBio | 10ug | EUR 391.2 |
![]() Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-200ug |
|||
QP7508-ec-200ug | EnQuireBio | 200ug | EUR 1338 |
![]() Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-500ug |
|||
QP7508-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
![]() Recombinant E.coli S-ribosylhomocysteine lyase Protein, His, E.coli-50ug |
|||
QP7508-ec-50ug | EnQuireBio | 50ug | EUR 522 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-100ug |
|||
QP6448-ye-100ug | EnQuireBio | 100ug | EUR 685.2 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-200ug |
|||
QP6448-ye-200ug | EnQuireBio | 200ug | EUR 1077.6 |
![]() Recombinant Human N-glycosylase/ DNA lyase Protein, His, Yeast-500ug |
|||
QP6448-ye-500ug | EnQuireBio | 500ug | EUR 1806 |
![]() Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-1mg |
|||
QP6149-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
![]() CCBL1 Cysteine Conjugate-Beta Lyase Cytoplasmic Human Recombinant Protein |
|||
PROTQ16773 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: CCBL1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 445 amino acids (1-422 a.a) and having a molecular mass of 50.3kDa. CCBL1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
![]() Recombinant 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase (HMGCL) |
|||
4-RPD685Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase expressed in: E.coli |
![]() Recombinant 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase (HMGCL) |
|||
4-RPD685Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse 3-Hydroxymethyl-3-Methylglutaryl Coenzyme A Lyase expressed in: E.coli |
![]() Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-100ug |
|||
QP6149-ec-100ug | EnQuireBio | 100ug | EUR 685.2 |
![]() Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-10ug |
|||
QP6149-ec-10ug | EnQuireBio | 10ug | EUR 326.4 |
![]() Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-200ug |
|||
QP6149-ec-200ug | EnQuireBio | 200ug | EUR 1077.6 |
![]() Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-500ug |
|||
QP6149-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
![]() Recombinant Human Cytochrome c-type heme lyase Protein, GST, E.coli-50ug |
|||
QP6149-ec-50ug | EnQuireBio | 50ug | EUR 434.4 |
![]() anti-2 Hydroxy phytanoyl CoA lyase |
|||
YF-PA18196 | Abfrontier | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to 2 Hydroxy phytanoyl CoA lyase |
![]() anti-2 Hydroxy phytanoyl CoA lyase |
|||
YF-PA18197 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to 2 Hydroxy phytanoyl CoA lyase |
![]() Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-10ug |
|||
QP5607-ec-10ug | EnQuireBio | 10ug | EUR 326.4 |
![]() Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-1mg |
|||
QP5607-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
![]() Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-50ug |
|||
QP5607-ec-50ug | EnQuireBio | 50ug | EUR 434.4 |
![]() Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-100ug |
|||
QP5607-ec-100ug | EnQuireBio | 100ug | EUR 685.2 |
![]() Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-200ug |
|||
QP5607-ec-200ug | EnQuireBio | 200ug | EUR 1077.6 |
![]() Recombinant Human ACLY/ acly/ ATP citrate lyase Protein, His-SUMO, E.coli-500ug |
|||
QP5607-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
![]() Recombinant Human Steroid 17-alpha-hydroxylase/ 17,20 lyase Protein, GST, E.coli-1mg |
|||
QP5904-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
×